Skip to main content
Erschienen in: Journal of Cancer Survivorship 6/2021

24.11.2020

Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: descriptive study

verfasst von: Alejandro Gallego, Beatriz Martínez, Ismael Ghanem, José Miguel Cantero, Enrique Espinosa, Beatriz Castelo, Pilar Zamora, Leticia Ruiz-Gimenez, Andrés Redondo, Jaime Feliu

Erschienen in: Journal of Cancer Survivorship | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Long-term cancer survivors (LTCS) are a vulnerable and continued growing population. To date, only few studies have been conducted in the Spanish population; none of them with a comprehensive analysis of the most common problems identified for cancer survivors in order to improve their care and quality of life.

Methods

We conducted an observational descriptive study in 347 patients recruited between January 2015 and December 2016 from our newly created medical office for the specific care and follow-up of LTCS. Variables that describe the medical history were completed by the oncologist and measures on common problems previously reported for LTCS, related to cancer diagnosis and treatment, function, lifestyle, and emotional concerns, were collected from the patient.

Results

The mean age of our patients was 65.1 years at the time of the study and a median time without any antitumor treatment of 5.7 years. At the time of cancer diagnosis, 298 patients (85.9%) had at least one related chronic disease and 184 patients (53%) were retired. In addition, in 17.9% of those who continued working, income had been reduced. The incidence of health problems showed an increase during follow-up, even after 5 years, and required evaluation in an emergency department in 157 cases (45.3%). Regardless of age or sex, 239 patients (68.9%) had a significant decrease in sexual activity and 120 (34.6%) were diagnosed with clinical depression.

Conclusions

LTCS are patients with significantly high socioeconomic, labor, sexual, health, and psychological problems, 5 years after completion of cancer treatment, especially in older survivors.

Implications for Cancer Survivor

Common concerns of LTCS were identified and are consistent across many countries. It is important to realize that even 5 or so years following treatment, both medical and non-medical problems can exist and may need attention by an expert.
Literatur
1.
Zurück zum Zitat De Angelis R, Sant M, Coleman MP, EUROCARE 5 Working Group, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population based study. Lancet Oncol. 2014;15:23–34.CrossRef De Angelis R, Sant M, Coleman MP, EUROCARE 5 Working Group, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population based study. Lancet Oncol. 2014;15:23–34.CrossRef
2.
Zurück zum Zitat Las Cifras del Cáncer en España 2016 [Internet]. Sociedad Española de Oncología Médica. Available at: http://www.seom.org. Last accessed 29 October 2018. Las Cifras del Cáncer en España 2016 [Internet]. Sociedad Española de Oncología Médica. Available at: http://​www.​seom.​org. Last accessed 29 October 2018.
3.
Zurück zum Zitat Galceran J, Ameijide A. Carulla et al. REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul;19(7):799–825.CrossRef Galceran J, Ameijide A. Carulla et al. REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul;19(7):799–825.CrossRef
4.
5.
Zurück zum Zitat Brozos Vázquez E, Vázquez Rivera F, Cueva Bañuelos J, Barón Duarte FJ. Supervivientes al cáncer en España: Situación actual, Monográfico SEOM de largos supervivientes en cáncer [Internet]. Sociedad Española de Oncología Médica. Available at: http://www.seom.org. Last accessed 3 November 2020. Brozos Vázquez E, Vázquez Rivera F, Cueva Bañuelos J, Barón Duarte FJ. Supervivientes al cáncer en España: Situación actual, Monográfico SEOM de largos supervivientes en cáncer [Internet]. Sociedad Española de Oncología Médica. Available at: http://​www.​seom.​org. Last accessed 3 November 2020.
6.
Zurück zum Zitat Shakeel S, Tung J, Rahal R, Finley C. Evaluation of factors associated with unmet needs in adult cancer survivors in Canada. JAMA Netw Open. 2020;3(3):e200506.CrossRef Shakeel S, Tung J, Rahal R, Finley C. Evaluation of factors associated with unmet needs in adult cancer survivors in Canada. JAMA Netw Open. 2020;3(3):e200506.CrossRef
7.
Zurück zum Zitat Nelson MB, Meeske K. Recognizing health risk in childhood cancers survivors. J Am Acad Nurse Pract. 2005;17:96–103.CrossRef Nelson MB, Meeske K. Recognizing health risk in childhood cancers survivors. J Am Acad Nurse Pract. 2005;17:96–103.CrossRef
8.
Zurück zum Zitat Reulen RC, Winter DL, Lancashire ER, Zeegers MP, Jenney ME, Walters SJ, et al. Health-status of adult survivors of childhood cancer: a large-scale population-based study from the British Childhood Cancer Survivor Study. Int J Cancer. 2007;121(3):633–40.CrossRef Reulen RC, Winter DL, Lancashire ER, Zeegers MP, Jenney ME, Walters SJ, et al. Health-status of adult survivors of childhood cancer: a large-scale population-based study from the British Childhood Cancer Survivor Study. Int J Cancer. 2007;121(3):633–40.CrossRef
9.
Zurück zum Zitat Bouhnik AD, Bendiane MK, Cortaredona S, et al. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open. 2015;5:3.CrossRef Bouhnik AD, Bendiane MK, Cortaredona S, et al. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open. 2015;5:3.CrossRef
10.
Zurück zum Zitat Ben Charif A, Bouhnik AD, Courbière B, Rey D, Préau M, Bendiane MK, et al. Sexual health problems in French cancer survivors 2 years after diagnosis-the national VICAN survey. J Cancer Surviv. 2016;10(3):600–9.CrossRef Ben Charif A, Bouhnik AD, Courbière B, Rey D, Préau M, Bendiane MK, et al. Sexual health problems in French cancer survivors 2 years after diagnosis-the national VICAN survey. J Cancer Surviv. 2016;10(3):600–9.CrossRef
11.
Zurück zum Zitat Rowland JH, Kent EE, Forsythe LP, et al. Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer. 2013;119(Suppl 11(011)):2094–108.CrossRef Rowland JH, Kent EE, Forsythe LP, et al. Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer. 2013;119(Suppl 11(011)):2094–108.CrossRef
12.
Zurück zum Zitat Truant TL, Fitch MI, O'Leary C, Stewart J. Global perspectives on cancer survivorship: from lost in transition to leading into the future. Can Oncol Nurs J. 2017;27(3):287–94.PubMedPubMedCentral Truant TL, Fitch MI, O'Leary C, Stewart J. Global perspectives on cancer survivorship: from lost in transition to leading into the future. Can Oncol Nurs J. 2017;27(3):287–94.PubMedPubMedCentral
13.
Zurück zum Zitat Maddison AR, Asada Y, Urquhart R. Inequity in access to cancer care: a review of the Canadian literature. Cancer Causes Control. 2011;22(3):359–66.CrossRef Maddison AR, Asada Y, Urquhart R. Inequity in access to cancer care: a review of the Canadian literature. Cancer Causes Control. 2011;22(3):359–66.CrossRef
14.
Zurück zum Zitat Zhao Y, Brettle A, Qiu L. The effectiveness of shared care in cancer survivors-a systematic review. Int J Integr Care. 2018;18(4):2.CrossRef Zhao Y, Brettle A, Qiu L. The effectiveness of shared care in cancer survivors-a systematic review. Int J Integr Care. 2018;18(4):2.CrossRef
15.
Zurück zum Zitat Lagergren P, Schandl A, Aaronson NK, Adami HO, Lorenzo F, Denis L, et al. Cancer survivorship: an integral part of Europe's research agenda. Mol Oncol. 2019;13(3):624–35.CrossRef Lagergren P, Schandl A, Aaronson NK, Adami HO, Lorenzo F, Denis L, et al. Cancer survivorship: an integral part of Europe's research agenda. Mol Oncol. 2019;13(3):624–35.CrossRef
16.
Zurück zum Zitat Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book. 2016;35:231–9.CrossRef Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book. 2016;35:231–9.CrossRef
17.
Zurück zum Zitat Brierley J, Gospodarowicz MK, Wittekind CH (Eds.). TNM classification of malignant tumours. 8th ed. Oxford; Hoboken: John Wiley & Sons, Inc.; 2017. Brierley J, Gospodarowicz MK, Wittekind CH (Eds.). TNM classification of malignant tumours. 8th ed. Oxford; Hoboken: John Wiley & Sons, Inc.; 2017.
18.
Zurück zum Zitat Gotay CC, Pagano IS. Assessment of survivor concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5:15.CrossRef Gotay CC, Pagano IS. Assessment of survivor concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5:15.CrossRef
19.
Zurück zum Zitat Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) (I). Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRef Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) (I). Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRef
20.
Zurück zum Zitat Alonso J, Prieto L, Anto JM. La versión española del SF-36 Heatlh Survey (Cuestionario de Salud SF 36): un instrumento para la medida de los resultados clínicos. Med Clin. 1995;104:771–6. Alonso J, Prieto L, Anto JM. La versión española del SF-36 Heatlh Survey (Cuestionario de Salud SF 36): un instrumento para la medida de los resultados clínicos. Med Clin. 1995;104:771–6.
21.
Zurück zum Zitat Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69–77.CrossRef Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69–77.CrossRef
22.
Zurück zum Zitat Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 2003 Mar;107(3):216–21.CrossRef Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 2003 Mar;107(3):216–21.CrossRef
23.
Zurück zum Zitat Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRef Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRef
24.
Zurück zum Zitat Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol. 2013;31:4465–70.CrossRef Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol. 2013;31:4465–70.CrossRef
25.
Zurück zum Zitat Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Lunsford NB, et al. Long-term survivorship care after cancer treatment - summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst. 2018;110(12):1300–10.CrossRef Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Lunsford NB, et al. Long-term survivorship care after cancer treatment - summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst. 2018;110(12):1300–10.CrossRef
26.
Zurück zum Zitat Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.CrossRef Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.CrossRef
27.
Zurück zum Zitat Gunnes MW, Lie RT, Bjørge T, Ghaderi S, Syse A, Ruud E, et al. Suicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-a national cohort study. Int J Cancer. 2017 Feb;140(3):575–80.CrossRef Gunnes MW, Lie RT, Bjørge T, Ghaderi S, Syse A, Ruud E, et al. Suicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-a national cohort study. Int J Cancer. 2017 Feb;140(3):575–80.CrossRef
28.
Zurück zum Zitat McDougall GJ Jr, Oliver JS, Scogin F. Memory and cancer: a review of the literature. Arch Psychiatr Nurs. 2014 Jun;28(3):180–6.CrossRef McDougall GJ Jr, Oliver JS, Scogin F. Memory and cancer: a review of the literature. Arch Psychiatr Nurs. 2014 Jun;28(3):180–6.CrossRef
29.
Zurück zum Zitat Encuesta Nacional de Salud 2011-2012 [Internet]. Instituto Nacional de Estadística, España. Available at: http://www.ine.es. Last accessed 25 November 2018. Encuesta Nacional de Salud 2011-2012 [Internet]. Instituto Nacional de Estadística, España. Available at: http://​www.​ine.​es. Last accessed 25 November 2018.
30.
Zurück zum Zitat Hudson MM, Tyc VL, Jayawardene DA, Gattuso J, Quargnenti A, Greenwald C, et al. Feasibility of implementing health promotion interventions to improve health-related quality of life. Int J Cancer Suppl. 1999;12:138–42.CrossRef Hudson MM, Tyc VL, Jayawardene DA, Gattuso J, Quargnenti A, Greenwald C, et al. Feasibility of implementing health promotion interventions to improve health-related quality of life. Int J Cancer Suppl. 1999;12:138–42.CrossRef
31.
Zurück zum Zitat Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2363–73.CrossRef Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2363–73.CrossRef
32.
Zurück zum Zitat Paul CL, Tzelepis F, Boyes AW, et al. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. J Cancer Surviv. 2019;13:687–94.CrossRef Paul CL, Tzelepis F, Boyes AW, et al. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. J Cancer Surviv. 2019;13:687–94.CrossRef
33.
Zurück zum Zitat Cortés-Ibáñez FO, Jaramillo-Calle DA, Vinke PC, et al. Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort. J Cancer Surviv. 2020;14:377–85.CrossRef Cortés-Ibáñez FO, Jaramillo-Calle DA, Vinke PC, et al. Comparison of health behaviours between cancer survivors and the general population: a cross-sectional analysis of the Lifelines cohort. J Cancer Surviv. 2020;14:377–85.CrossRef
34.
Zurück zum Zitat Azrad M, Demark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep. 2014;3(1):9–15.CrossRef Azrad M, Demark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep. 2014;3(1):9–15.CrossRef
35.
Zurück zum Zitat Shankar A, Prasad N, Roy S, et al. Sexual dysfunction in females after cancer treatment: an unresolved issue. Asian Pac J Cancer Prev. 2017 May;18(5):1177–82.PubMedPubMedCentral Shankar A, Prasad N, Roy S, et al. Sexual dysfunction in females after cancer treatment: an unresolved issue. Asian Pac J Cancer Prev. 2017 May;18(5):1177–82.PubMedPubMedCentral
36.
Zurück zum Zitat Junuzovic D, Hasanbegovic M, Omerbegovic D. Erectile dysfunction as a complication after treatment of prostate cancer. Mater Soc. 2011;23(4):230–1. Junuzovic D, Hasanbegovic M, Omerbegovic D. Erectile dysfunction as a complication after treatment of prostate cancer. Mater Soc. 2011;23(4):230–1.
37.
Zurück zum Zitat Bober SL, Michaud AL, Recklitis CJ. Finding sexual health aids after cancer: are cancer centers supporting survivors’ needs? J Cancer Surviv. 2019;13:224–30.CrossRef Bober SL, Michaud AL, Recklitis CJ. Finding sexual health aids after cancer: are cancer centers supporting survivors’ needs? J Cancer Surviv. 2019;13:224–30.CrossRef
Metadaten
Titel
Cancer survivors referred to a long-term survivorship outpatient service within academic medical oncology: descriptive study
verfasst von
Alejandro Gallego
Beatriz Martínez
Ismael Ghanem
José Miguel Cantero
Enrique Espinosa
Beatriz Castelo
Pilar Zamora
Leticia Ruiz-Gimenez
Andrés Redondo
Jaime Feliu
Publikationsdatum
24.11.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 6/2021
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00973-w

Weitere Artikel der Ausgabe 6/2021

Journal of Cancer Survivorship 6/2021 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.